Bolt Biotherapeutics (NASDAQ:BOLT) Research Coverage Started at Lake Street Capital
Lake Street Capital assumed coverage on shares of Bolt Biotherapeutics (NASDAQ:BOLT – Free Report) in a report published on Tuesday, MarketBeat reports. The firm issued a buy rating and a $4.00 price objective on the stock. BOLT has been the subject of several other reports. Stifel Nicolaus cut their target price on shares of Bolt […]
Lake Street Capital assumed coverage on shares of Bolt Biotherapeutics (NASDAQ:BOLT – Free Report) in a report published on Tuesday, MarketBeat reports. The firm issued a buy rating and a $4.00 price objective on the stock. BOLT has been the subject of several other reports. Stifel Nicolaus cut their target price on shares of Bolt […]
